🔗 Permalink

Inventor profile of:

Thomas WESSEL

City:

Lenox, Massachusetts

Country:

United States

Published Applications:

17

Last publication date:

2022-12-22

Top Assignees for applications by Thomas WESSEL

The entities that hold a legal rights for patent applications filed by inventor WESSEL Thomas:

SEPRACOR INC. 7 Marlborough, MA United States
Sunovion Pharmaceuticals Inc. 5 Marlborough, MA United States
Sunovion Inc. 2 Marlborough, MA United States
Cliff-Cartwright Corporation 1 Wellesley Hills, MA United States
SEPRACOR INC. 1 Marlborough, NY United States

Recent patent applications by WESSEL Thomas

Thomas WESSEL from Lenox, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2022-12-22

US20220401387A1

Human necessities

COMPOSITIONS AND METHODS AFFECTING EXERCISE PERFORMANCE

#2 | 2020-08-20

US20200261382A1

Human necessities

Compositions and methods affecting exercise performance

#3 | 2018-05-03

US20180116976A1

Human necessities

METHODS AND COMPOSITIONS FOR UNWANTED OR ABNORMAL MUSCLE CONTRACTIONS

#4 | 2014-11-20

US20140343069A1

Human necessities

COMBINATION OF SEDATIVE AND A NEUROTRANSMITTER MODULATOR, AND METHODS FOR IMPROVING SLEEP QUALITY AND TREATING DEPRESSION

#5 | 2014-10-23

US20140315910A1

Human necessities

Combinations of Eszopiclone and Trans 4-(3,4-Dichlorophenyl)-1,2,3,4-Tetrahydro-N-Methyl-1-Napthalenamine or Trans 4-(3,4-Dichlorophenyl)-1,2,3,4-Tetrahydro-1-Napthalenamine, and Methods of Treatment of Menopause and Mood, Anxiety, and Cognitive Disorders

#6 | 2013-03-14

US20130065904A1

Human necessities

Combinations of Eszopiclone and Trans 4-(3,4-Dichlorophenyl)-1,2,3,4-Tetrahydro-N-Methyl-1-Napthalenamine or Trans 4-(3,4-Dichlorophenyl)-1,2,3,4-Tetrahydro-1-Napthalenamine, and Methods of Treatment of Menopause and Mood, Anxiety, and Cognitive Disorders

#7 | 2012-05-17

US20120123164A1

Human necessities

Process for preparation of trans 4-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydro-1Napthalenamine

#8 | 2012-05-17

US20120122874A1

Human necessities

COMBINATION OF A SEDATIVE AND A NEUROTRANSMITTER MODULATOR, AND METHODS FOR TREATING DEPRESSION

#9 | 2012-02-09

US20120035182A1

Human necessities

Methods of treatment of chronic pain using eszopiclone

#10 | 2010-11-04

US20100280038A1

Human necessities

Methods of treatment of chronic pain using eszopiclone

#11 | 2009-04-30

US20090111818A1

Human necessities

Combinations of Eszopiclone and O-Desmethylvenlafaxine, and Methods of Treatment of Menopause and Mood, Anxiety, and Cognitive Disorders

#12 | 2009-04-30

US20090111817A1

Human necessities

Combinations of Eszopiclone and an Antidepressant

#13 | 2008-11-27

US20080293726A1

Human necessities

Combinations of Eszopiclone and Trans 4-(3,4-Dichlorophenyl)-1,2,3,4-Tetrahydro-N-Methyl-1-Napthalenamine or Trans 4-(3,4-Dichlorophenyl)-1,2,3,4-Tetrahydro-1-Napthalenamine, and Methods of Treatment of Menopause and Mood, Anxiety, and Cognitive Disorders

#14 | 2007-12-27

US20070299055A1

Human necessities

Combination of sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression

#15 | 2005-10-06

US20050222157A1

Human necessities

Methods of treatment of menopause and perimenopause using eszopiclone

#16 | 2005-10-06

US20050222156A1

Human necessities

Methods of treatment of chronic pain using eszopiclone

#17 | 2005-08-11

US20050176680A1

Human necessities

Combination of sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression

InventorID:

141085 ⎘